Unknown Manufacturer
Ajmaline is an antiarrhythmic used to manage a variety of forms of tachycardias.
Ajmaline is an antiarrhythmic used to manage a variety of forms of tachycardias.
The class I antiarrhythmic agents interfere with the sodium channel. A class IA agent lengthens the action potential (right shift) which brings about improvement in abnormal heart rhythms. This drug in particular has a high affinity for the Nav 1.5 sodium channel.
对各种室上性及室性心律失常均有效，对预激综合征伴发的室上性心动过速、房颤、房扑，其有效率可达80％～90％。对室上性心动过速复律效果也佳。
3 associated conditions
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
No patents found under this name
Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.
